Viewing Study NCT03681561


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-01-13 @ 3:29 AM
Study NCT ID: NCT03681561
Status: RECRUITING
Last Update Posted: 2025-08-27
First Post: 2018-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
Sponsor: Veronika Bachanova
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module